WHO ICTRP trial

Clinical observation on the effect of Ningmitai capsule in treating upper…

ChiCTR2000040740 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2000040740
Public title Clinical observation on the effect of Ningmitai capsule in treating upper urinary tract Calculi after operation
Scientific title Clinical observation on the effect of Ningmitai capsule in treating upper urinary Calculi after minimally invasive lithotripsy through natural lumen
Primary sponsor Guangdong Provincial Hospital of traditional Chinese medicine
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Postoperative upper urinary tract Calculi
Interventions Ningmitai group: Take Ningmitai capsules;Tamsorosin group:Take Tamsulosin Rossin sustained release capsulesTake Tamsulosin;Tonglinguben group:Take Tonglin Guben No. 1 Granule;Ningmitai + Tamsulosin group:A combination of Ningmitai capsules…
Registration date Dec 8, 2020
Target size Ningmitai group:50;Tamsorosin group:50;Tonglinguben group:50;Ningmitai +…
Secondary IDs ChiMCTR2100004664
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations